The oncogenic potential of a mutant TP53 gene explored in two spontaneous lung cancer mice models

Lung cancer is the number one cancer killer worldwide. A major drawback in the lung cancer treatment field is the lack of realistic mouse models that replicate the complexity of human malignancy and immune contexture within the tumor microenvironment.